The mere presence of a drug approved by the federal food and drug administration for opioid overdose reversal is not indicative of a crime and shall not be used to support probable cause.
Source: L. 2024: Entire section added, (HB 24-1037), ch. 458, p. 3164, § 4, effective June 6.